Aptapharma Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for APTAPHARMA INC, and what generic and branded alternatives to APTAPHARMA INC drugs are available?
APTAPHARMA INC has four approved drugs.
Summary for Aptapharma Inc
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Aptapharma Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aptapharma Inc | SILDENAFIL CITRATE | sildenafil citrate | FOR SUSPENSION;ORAL | 213041-001 | Aug 6, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Aptapharma Inc | FLUOXETINE HYDROCHLORIDE | fluoxetine hydrochloride | SOLUTION;ORAL | 216953-001 | Nov 15, 2022 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Aptapharma Inc | OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | FOR SUSPENSION;ORAL | 212858-001 | Aug 30, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Aptapharma Inc | IBUPROFEN | ibuprofen | SUSPENSION;ORAL | 210602-001 | Nov 23, 2018 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
